Trial Profile

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Linagliptin (Primary) ; Glimepiride
Indications Type 2 diabetes mellitus
Focus Adverse reactions

Most Recent Events

23 Sep 2020 Status changed from active, no longer recruiting to completed.
02 Jul 2019 New trial record
25 Jun 2019 Results using real world data to predict the findings of the CAROLINA trial comparing linagliptin vs. glimepiride in patients with type 2 diabetespublished in the Diabetes Care

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com